The Korean Journal of Oral and Maxillofacial Pathology (대한구강악안면병리학회지)

Korean Academy of Oral and Maxillofacial Pathology (대한구강악안면병리학회)
권호 표지
DOI QR코드

DOI QR Code

Apoptosis and Autophagy Induced by Methanol Extract of Kochia scoparia in Human Mucoepidermoid Carcinoma Cell Line

점액표피양암종 세포주에서 Kochia scoparia 추출물의 세포자멸과 자가포식 유도 효과

  • Do, Mihyang (Research Institute for Oral Biotechnology, School of Dentistry, Pusan National University) ;
  • Ryu, Mi Heon (Department of Oral Pathology, BK21 Plus project, School of Dentistry, Pusan National University) ;
  • Kim, Uk-Kyu (Department of Oral and Maxillofacial Surgery, School of Dentistry, Pusan National University)
  • 도미향 (부산대학교 구강생물공학연구소) ;
  • 유미현 (부산대학교 치의학전문대학원 구강병리학 교실, BK21 플러스 사업단) ;
  • 김욱규 (부산대학교 치의학전문대학원 구강악안면외과학 교실)
  • Received : 2018.11.29
  • Accepted : 2018.12.14
  • Published : 2018.12.31
⟨ Previous Next ⟩

Abstract

Natural products are vastly utilized as a source of chemotherapeutic agents for human cancers. Kochia scopraia is traditionally used for the cure of urological and dermatological diseases. Recently, methanol extract of Kochia scoparia (MEKS) has been shown to have anti-cancer activity to various human cancers. However, there is no report demonstrating the anti-cancer activity of MEKS in human mucoepidermoid carcinoma (MEC) cells. In this study, the authors studied the effects of MEKS on the cell proliferation and underlying mechanism in YD15 human MEC cells. MEKS decreased YD15 cell proliferation proven by trypan blue exclusion assay and induced apoptosis, evidenced by cell cycle analysis and western blotting. Autophagy induction by MEKS was verified by western blotting. In addition, MEKS regulated the expression of phosphorylated Akt, phosphorylated p38 and Nrf2 protein. This results can imply that MEKS might be a potential candidate for the treatment of human MEC cells.

Keywords

Acknowledgement

Supported by : Pusan National University

References

  1. Kwon H, Lim W, Choi Y, Nam J, Han C, Kim J, Ko Y, Kim I, Kim S, Kim M, Kim O, Choi H, Kim O: High-grade oncocytic mucoepidermoid carcinoma of the minor salivary gland origin: a case report with immunohistochemical study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;109:e72-77. https://doi.org/10.1016/j.tripleo.2010.01.026
  2. Guzzo M, Andreola S, Sirizzotti G, Cantu G: Mucoepidermoid carcinoma of the salivary glands: clinicopathologic review of 108 patients treated at the National Cancer Institute of Milan. Ann Surg Oncol 2002;9:688-695. https://doi.org/10.1007/BF02574486
  3. Vargas PA, Gerhard R, Araujo Filho VJ, de Castro IV: Salivary gland tumors in a Brazilian population: a retrospective study of 124 cases. Rev Hosp Clin Fac Med Sao Paulo 2002;57:271-276. https://doi.org/10.1590/S0041-87812002000600005
  4. Seifert G, Brocheriou C, Cardesa A, Eveson JW: WHO International Histological Classification of Tumours. Tentative Histological Classification of Salivary Gland Tumours. Pathol Res Pract 1990;186:555-581. https://doi.org/10.1016/S0344-0338(11)80220-7
  5. Batsakis JG, Luna MA: Histopathologic grading of salivary gland neoplasms: I. Mucoepidermoid carcinomas. Ann Otol Rhinol Laryngol 1990;99:835-838. https://doi.org/10.1177/000348949009901015
  6. Raguse JD, Gath HJ, Bier J, Riess H, Oettle H: Docetaxel (Taxotere) in recurrent high grade mucoepidermoid carcinoma of the major salivary glands. Oral Oncology Extra 2004;40:5-7. https://doi.org/10.1016/S1741-9409(03)00003-7
  7. Yu HJ, Ahn CH, Yang IH, Won DH, Jin B, Cho NP, Hong SD, Shin JA, Cho SD: Apoptosis induced by methanol extract of Potentilla discolor in human mucoepidermoid carcinoma cells through STAT3/PUMA signaling axis. Mol Med Rep 2018;17:5258-5264.
  8. Ko WG, Kang TH, Lee SJ, Kim YC, Lee BH: Rotundifuran, a labdane type diterpene from Vitex rotundifolia, induces apoptosis in human myeloid leukaemia cells. Phytother Res 2001;15:535-537. https://doi.org/10.1002/ptr.743
  9. Subramaniam D, May R, Sureban SM, Lee KB, George R, Kuppusamy P, Ramanujam RP, Hideg K, Dieckgraefe BK, Houchen CW, Anant S: Diphenyl difluoroketone: a curcumin derivative with potent in vivo anticancer activity. Cancer Res 2008;68:1962-1969. https://doi.org/10.1158/0008-5472.CAN-07-6011
  10. Sebolt-Leopold JS: Development of anticancer drugs targeting the MAP kinase pathway. Oncogene 2000; 19, 6594-6599. https://doi.org/10.1038/sj.onc.1204083
  11. Balmanno K, Cook SJ: Tumour cell survival signalling by the ERK1/2 pathway. Cell Death Differ 2009;16:368-377. https://doi.org/10.1038/cdd.2008.148
  12. Peng Q, Deng Z, Pan H, Gu L, Liu O, Tang Z: Mitogenactivated protein kinase signaling pathway in oral cancer. Oncol Lett 2018; 15, 1379-1388.
  13. Wagner EF, Nebreda AR. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 2009;9:537-549. https://doi.org/10.1038/nrc2694
  14. Carnero A: The PKB/AKT pathway in cancer. Curr Pharm Des 2010; 16, 34-44. https://doi.org/10.2174/138161210789941865
  15. Osaki M, Oshimura M, Ito H: PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis 2004; 9, 667-676. https://doi.org/10.1023/B:APPT.0000045801.15585.dd
  16. Cantley LC: The phosphoinositide 3-kinase pathway. Science 2002;296: 1655-1657. https://doi.org/10.1126/science.296.5573.1655
  17. Han HY, Lee HE, Kim HJ, Jeong SH, Kim JH, Kim H, Ryu MH: Kochia scoparia induces apoptosis of oral cancer cells in vitro and in heterotopic tumors. J Ethnopharmacol 2016;192:431-441. https://doi.org/10.1016/j.jep.2016.09.019
  18. Kubo M, Matsuda H, Dai Y, Ido Y, Yoshikawa M: Studies on Kochiae Fructus. I. Antipruritogenic effect of 70% ethanol extract from kochiae fructus and its active component. Yakugaku Zasshi 1997;117:193-201. https://doi.org/10.1248/yakushi1947.117.4_193
  19. Wang J, Yuan L, Xiao H, Wang C, Xiao C, Wang Y, Liu X: A novel mechanism for momordin Ic-induced HepG2 apoptosis: involvement of PI3K- and MAPK-dependent PPARgamma activation. Food Funct 2014;5:859-868. https://doi.org/10.1039/c3fo60558b
  20. Bressenot A, Marchal S, Bezdetnaya L, Garrier J, Guillemin F, Plenat F: Assessment of apoptosis by immunohistochemistry to active caspase-3, active caspase-7, or cleaved PARP in monolayer cells and spheroid and subcutaneous xenografts of human carcinoma. J Histochem Cytochem 2009;57:289-300. https://doi.org/10.1369/jhc.2008.952044
  21. Akar U, Chaves-Reyez A, Barria M, Tari A, Sanguino A, Kondo Y, Kondo S, Arun B, Lopez-Berestein G, Ozpolat B: Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells. Autophagy 2008;4:669-679. https://doi.org/10.4161/auto.6083
  22. Piao MS, Park JJ, Choi JY, Lee DH, Yun SJ, Lee JB, Lee SC: Nrf2-dependent and Nrf2-independent induction of phase 2 detoxifying and antioxidant enzymes during keratinocyte differentiation. Arch Dermatol Res 2012;304:387-395. https://doi.org/10.1007/s00403-012-1215-7
  23. Wang YS, Wen ZQ, Li BT, Zhang HB, Yang JH: Ethnobotany, phytochemistry, and pharmacology of the genus Litsea: An update. J Ethnopharmacol 2016;181: 66-107. https://doi.org/10.1016/j.jep.2016.01.032
  24. Keum YS, Yu S, Chang PP, Yuan X, Kim JH, Xu C, Han J, Agarwal A, Kong AN: Mechanism of action of sulforaphane: inhibition of p38 mitogen-activated protein kinase isoforms contributing to the induction of antioxidant response element-mediated heme oxygenase-1 in human hepatoma HepG2 cells. Cancer Res 2006;66:8804-8813. https://doi.org/10.1158/0008-5472.CAN-05-3513
  25. Kocanova S, Buytaert E, Matroule JY, Piette J, Golab J, de Witte P, Agostinis P: Induction of heme-oxygenase 1 requires the p38MAPK and PI3K pathways and suppresses apoptotic cell death following hypericin-mediated photodynamic therapy. Apoptosis 2007;12:731-741. https://doi.org/10.1007/s10495-006-0016-x
  26. Jeong WS, Jun M, Kong AN: Nrf2: a potential molecular target for cancer chemoprevention by natural compounds. Antioxid Redox Signal 2006;8:99-106. https://doi.org/10.1089/ars.2006.8.99
  27. Choi ES, Oh S, Jang B, Yu HJ, Shin JA, Cho NP, Yang IH, Won DH, Kwon HJ, Hong SD, Cho SD: Silymarin and its active component silibinin act as novel therapeutic alternatives for salivary gland cancer by targeting the ERK1/2-Bim signaling cascade. Cell Oncol (Dordr) 2017;40:235-246.
  28. Grisanti S, Amoroso V, Buglione M, Rosati A, Gatta R, Pizzocaro C, Ferrari VD, Marini G: Cetuximab in the treatment of metastatic mucoepidermoid carcinoma of the salivary glands: a case report and review of literature. J Med Case Rep 2008;2:320. https://doi.org/10.1186/1752-1947-2-320
  29. Guimaraes DM, Almeida LO, Martins MD, Warner KA, Silva AR, Vargas PA, Nunes FD, Squarize CH, Nor JE, Castilho RM: Sensitizing mucoepidermoid carcinomas to chemotherapy by targeted disruption of cancer stem cells. Oncotarget 2016;7:42447-42460.